mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
0.055 |
0.7 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |